Company Aroma - Aromatherapy Investment Opportunity

company auroma is a premium aromatherapy brand operating in the luxury wellness space, providing holistic scenting solutions for the development of mind, body, and soul. established over 4 years ago, the company has built a reputable presence across both b2b and b2c channels, catering to national and global luxury clientele including premier hospitality groups such as hilton and marriott, retail chains, airport stores, corporate houses, and export markets across the usa, uk, italy, netherlands, sweden, and ireland.

 

the company offers a diverse and differentiated product portfolio encompassing premium essential oils available in 26 variants, ifra-compliant aroma and fragrance oils in 20+ variants with customisation options, luxury corporate and festive gift solutions, msds-certified incense sticks and cones in 8 variants, and commercial and personal scent machines and diffusers with app-controlled features. additionally, the business offers private labelling and scent matching services for luxury brands, underpinning a scalable b2b revenue model.

 

from a financial performance standpoint, the business recorded revenues of approximately ₹68.89 lakh in fy 2023, ₹60.29 lakh in fy 2024, and ₹57.01 lakh in fy 2025. the company successfully achieved a turnaround to positive ebitda of ₹1.83 lakh in fy 2025 (3% margin), following strategic restructuring and a deliberate shift towards high-margin b2b scenting partnerships. gross profit margins have grown significantly from 20% in fy 2023 to 52% in fy 2025, reflecting improved operational efficiency and product mix optimisation. pat margins have correspondingly improved from -15% in fy 2023 to +3% in fy 2025, evidencing the company's progression to sustainable profitability.

 

the business has been successfully operating in auto-pilot mode for 1.5 to 2 years without active founder involvement, making it an ideal acquisition candidate for investors or strategic buyers seeking a ready-to-scale platform. the founder's decision to sell is driven solely by relocation outside india and does not reflect any operational distress.

 

the aromatherapy and wellness market represents a compelling investment thesis: the global aromatherapy market is valued at usd 9.39 billion in 2024 and is projected to reach usd 21.67 billion by 2034 at a cagr of 8.72%. in india, the segment is expected to grow at an even more aggressive cagr of 11–19.5%, driven by rising wellness consciousness, cultural and religious demand, corporate gifting trends, and expanding export appetite for indian natural products.

 

the business carries significant unrealised upside: the d2c and e-commerce channels — previously active on shopify, amazon, flipkart, myntra, and tatacliq — are currently paused but can be restarted seamlessly, with the potential to deliver 2–3x revenue growth under active ownership. proprietary formulations backed by 60+ years of family business legacy provide a strong competitive moat that is difficult to replicate.